Carbidopa impurity F
CAS: 1458640-32-8
Ref. 3D-FH177492
| 1mg | 194.00 € | ||
| 2mg | 310.00 € | ||
| 5mg | 436.00 € | ||
| 10mg | 647.00 € | ||
| 25mg | 986.00 € |
Product Information
- (αS)-α-Hydrazinyl-3,4-dihydroxy-α-methylbenzenepropanoic acid ethyl esterCarbidopa EP impurity F
Carbidopa is an impurity of the drug L-DOPA, which is used as a treatment for Parkinson's disease. Carbidopa is a prodrug that is converted to L-DOPA by decarboxylase, an enzyme in the body. The conversion process can be inhibited by the presence of carbidopa impurity F (CIF), which binds to carboxamides and forms a stable complex with them. This prevents CIF from binding to decarboxylase and blocking its ability to convert carbidopa into L-DOPA. CIF has been shown to have anti-parkinsonian effects by reducing the severity of symptoms associated with Parkinson's disease such as muscular rigidity and tremors.
Chemical properties
Technical inquiry about: 3D-FH177492 Carbidopa impurity F
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
